Author: afnhi

HIV Vaccine Research A community and civil society perspective, and commentary on HVTN 702

Background: On 3rd February 2020, the US National Institute of Allergy and Infectious Diseases (NIAID) announced that HVTN 702, a large-scale HIV vaccine efficacy trial of a vaccine candidate, has stopped vaccinations because the vaccine does not prevent HIV. The trial, conducted at 14 sites across South Africa, followed more than 5400 HIV-negative 18–35-year-olds over […]

AfNHi Celebrates Dr. Manasseh Phiri

On Monday 22nd April 2019, AfNHi, an African led network of HIV prevention research advocates, learnt with a great sense of loss, that Dr Manasseh Phiri is no more. Dr Manasseh, fondly referred to as ‘Papa’ by his AfNHi family, is a founder member of AfNHi and has diligently served as a steering committee member […]

NPT Capacity Building Interests among African Civil Society Advocates

Background: The Africa Free of New HIV Infections (AfNHi) commissioned an assessment in order to map national level organisations undertaking biomedical HIV prevention research advocacy, or that have an interest therein. Opportunities and enablers for an expanded African led civil society network driving biomedical HIV prevention research advocacy were explored. Methods: Organisations were identified through […]

Environmental enablers for implementing biomedical HIV prevention research advocacy

Background: The Africa Free of New HIV Infections (AfNHi) commissioned an assessment in order to map national level organisations undertaking biomedical HIV prevention research advocacy, or that have an interest therein. Opportunities and enablers for an expanded African led civil society network driving biomedical HIV prevention research advocacy were explored. Methods: Organisations were identified through […]

African-Led Civil Society Network Characteristics

Background: The Africa Free of New HIV Infections (AfNHi) commissioned an assessment in order to map national level organisations undertaking biomedical HIV prevention research advocacy, or that have an interest therein. Opportunities and enablers for an expanded African led civil society network driving biomedical HIV prevention research advocacy were explored. Methods: Organisations were identified through […]

Advocacy Experiences by Steering Commitee

The section below provides in-country reflections from AfNHi steering committee members on doing HIV prevention research advocacy, as well as looking ahead as AfNHi into what might be needed to champion civil society advocacy in the future. Alice, UgandaMaureen, Malawi Morenike, NigeriaSydney, GhanaNtando, South AfricaRosemary, KenyaAlice, Uganda While there is some level of consultation at [...]

Advocacy Experiences by Country

This section presents country level discussions for the advocacy context in which different participants deliver their programmes. Case studies from stakeholder interviews and core group interviews are presented to highlight contextual enablers and challenges.   BotswanaZimbabweKenyaMalawiNigeriaTanzaniaUgandaBotswana It is easy, I participate at the Ministry of Health. I have been doing advocacy for many years, in [...]

Commemoration of OAU

For Africa, where a high burden of disease still persists, it is important that we find a safe, effective and affordable vaccine. It will be one of the most critically important tools to control the HIV epidemic in our region. Beyond controlling the epidemic, development of an effective HIV vaccine will likely be necessary to […]